SYSTEMS AND METHODS OF DROPLET-BASED SELECTION

• US 20110275063A1
• Filed: 07/10/2009
• Published: 11/10/2011
• Est. Priority Date: 07/11/2008
• Status: Abandoned Application

• Current Assignee: President and Fellows of Harvard College (Harvard Corporation)
• Original Assignee: President and Fellows of Harvard College (Harvard Corporation)
• Inventors: Heyman, John, Weitz, David A.
• Application Number:
  US13/003,417
• Publication Number:
  US 20110275063A1
• Time in Patent Office: Days
• US Class Current: 435/6.1
• CPC Class Codes: G01N 33/5008 for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
• CPC Class Codes: G01N 33/5436 with ligand physically entrapped within the solid phase liposomes G01N33/5432; immunological test elements G01N33/54386
• CPC Class Codes: G01N 33/6854 Immunoglobulins

Abstract

The present invention generally relates to fluidic droplets, and techniques for screening or sorting such fluidic droplets. In some embodiments, the fluidic droplets may contain cells (e.g., hybridoma cells) that can secrete various species, such as antibodies, for example. In one aspect, a plurality of fluidic droplets containing cells is screened to determine proteins, antibodies, polypeptides, peptides, nucleic acids, or the like. For example, cells able to secrete species such as antibodies may be se according to certain embodiments of the invention. Examples of such cells include, for instance, immortal cells such as hybridomas, or non-immortal cells such as B-cells. For instance, blood cells may be encapsulated within a plurality of fluidic droplets, and the cells able to produce antibodies may be determined. In some cases, expression or secretion levels may be determined using signaling entities, for example, determinable microparticles present within the fluidic droplet. Other aspects of the invention relate to kits involving such fluidic droplets, methods of promoting the making or use of such fluidic droplets, and the like.

Claims

1. A method, comprising:

providing a plurality of fluidic droplets contained within a liquid, wherein at least some of the fluidic droplets contain cells able to secrete a species;

culturing the cells to secrete the species; and

causing the secreted species to associate with the cells.

2. The method of claim 1, further comprising determining the secreted species using a signaling entity.

3. The method of claim 2, wherein the signaling entity comprises a comprising a microparticle and an agent, immobilized relative to the microparticle, able to bind the secreted species.

4. The method of claim 1, comprising separating droplets containing the cells able to secrete the species from droplets that do not contain cells able to secrete the species.

5. The method of claim 1, wherein the species is a protein or a peptide.

6. The method of claim 1, wherein the species is fluorescent.

7. The method of claim 1, wherein the species is GFP.

8. The method of claim 1, wherein the species is an antibody or portion thereof.

9. The method of claim 1, further comprising determining the species within the fluidic droplets.

10. The method of claim 1, wherein associating the secreted species with the cells comprises exposing the cells to a binding species able to bind to the secreted species and to the cells.

11. The method of claim 1, further comprising amplifying DNA from the cells.

12. The method of claim 1, further comprising sequencing DNA from the cells.

13. The method of claim 12, further comprising inserting at least a portion of the DNA in a host cell.

14. The method of claim 1, further comprising cloning DNA from the cells.

15. The method of claim 1, wherein the cells are contained within the plurality of fluidic droplets at an average ratio of no more than about 1 cell/fluidic droplet.

16. A method, comprising:

providing a plurality of fluidic droplets contained within a liquid, wherein at least some of the fluidic droplets contain non-immortal cells;

causing a species secreted by the non-immortal cells within the fluidic droplets to associate with the cells within the fluidic droplets; and

determining a characteristic of the species secreted by the non-immortal cells within the fluidic droplets.

17. The method of claim 16, further comprising determining the secreted species using a signaling entity.

18. The method of claim 17, wherein the signaling entity comprises a comprising a microparticle and an agent, immobilized relative to the microparticle, able to bind the secreted species.

19. The method of claim 16, further comprising exposing the species and the cells to a binding species able to bind to the secreted species and to the cells.

20. The method of claim 16, wherein the characteristic of the species is determined by exposing the non-immortal cell to a second cell.

21. The method of claim 16, wherein the second cell is a healthy cell.

22. The method of claim 16, wherein the second cell is a diseased cell.

23. The method of claim 16, wherein the second cell is a cancer cell.

24. The method of claim 16, wherein the characteristic of the species is determined by exposing the non-immortal cell to a first target and a second target.

25. The method of claim 16, wherein the first target is a cell and the second target is a cell.

26. The method of claim 16, wherein the first target is a protein and the second target is a protein.

27. The method of claim 16, wherein the first target comprises a first signaling entity and the second target comprises a second signaling entity.

28. The method of claim 27, wherein determining the characteristic of the species comprising determining association of the first signaling entity and the second signaling entity.

29. The method of claim 16, wherein the species is a protein or a peptide.

30. The method of claim 16, wherein the species is an antibody or portion thereof.

31. The method of claim 16, further comprising culturing the cells within the fluidic droplets.

32. The method of claim 16, wherein the determination is done in the presence of the non-immortal cells within the fluidic droplets.

33. A method, comprising:

providing a plurality of fluidic droplets contained within a liquid, wherein some of the fluidic droplets contain cells able to secrete an species and some of the fluidic droplets contain cells not able to secrete the species;

causing the species secreted by the cells able to secrete the species to associate therewith; and

at least partially separating the fluidic droplets containing the cells able to secrete the species from the fluidic droplets containing the cells not able to secrete the species.

34. The method of claim 33, wherein the species is an antibody or portion thereof.

35. The method of claim 33, wherein the species is a protein or a peptide.

36. A method, comprising:

providing a plurality of fluidic droplets contained within a liquid, wherein at least some of the fluidic droplets contain antibody-producing cells;

culturing the antibody-producing cells to secrete antibodies or portions thereof; and

causing the secreted antibodies or portions thereof to associate with the antibody-producing cells.

37. The method of claim 36, wherein at least some of the cells are hybridomas.

38. The method of claim 36, wherein the antibody-producing cells are cultured within the fluidic droplets.

39. The method of claim 36, further comprising amplifying DNA from the cells.

40. The method of claim 36, further comprising sequencing DNA from the antibody-producing cells.

41. The method of claim 36, further comprising cloning DNA from the cells.

42. The method of claim 41, wherein the DNA is amplified prior to cloning.

43. The method of claim 42, further comprising inserting at least a portion of the DNA in a host cell.

44. The method of claim 36, wherein the inserted portion of the DNA comprises a sequence encoding at least a portion of an antibody.

45. The method of claim 36, further comprising determining the antibodies within the fluidic droplets.

46. A composition, comprising:

a fluidic droplet, contained in a liquid, containing a first binding partner immobilized relative to a first enzyme portion, and a second binding partner immobilized relative to a second enzyme portion,

wherein association of the first binding partner and the second binding partner causes the first and second enzyme portions to exhibit enzymatic activity.

47. The composition of claim 46, wherein the fluidic droplet has an average diameter of less than about 1 mm.

48. The composition of claim 46, wherein the first binding partner comprises an antibody.

49. The composition of claim 48, wherein the second binding partner comprises a target recognized by the antibody.

50. The composition of claim 48, wherein the target is a protein.

51. The composition of claim 48, wherein the target is a cell.

52. The composition of claim 46, further comprising a cell contained within the fluidic droplet.

53. The composition of claim 46, wherein the first binding partner specifically binds the second binding partner.

54. The composition of claim 46, wherein the first enzyme portion is horseradish peroxidase A, and the second enzyme portion is horseradish peroxidase B.